Alnylam Pharmaceuticals Market Cap

Alnylam Pharmaceuticals has a market cap or net worth of 945.8 billion as of December 31, 2025. Its market cap has increased by 48.17% in one year.

Market Cap

945.80B

Enterprise Value

946.68B

Revenue

58.88B

Ranking

n/a

PE Ratio

1,183.61

Stock Price

8,380.00

Market Cap Chart

Since May 28, 2004, Alnylam Pharmaceuticals's market cap has increased from 1.32B to 945.80B, an increase of 71,399.75%. That is a compound annual growth rate of 35.55%.

Market Cap History

Date	Market Cap	% Change
Dec 30, 2025	941.80B	48.92%
Dec 31, 2024	632.43B	55.74%
Dec 29, 2023	406.09B	-28.80%
Dec 30, 2022	570.31B	37.16%
Dec 31, 2021	415.79B	38.38%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Wal-Mart de México	988.42B
Grupo Financiero Banorte	478.62B
Industrias Peñoles	389.27B
Arca Continental	334.21B
GMéxico Transportes	151.99B
FIBRA Prologis	124.37B
Promotora y Operadora de Infraestructura, S. A. B. de C. V.	112.92B
Fibra UNO	102.74B

Market Cap Rankings